Group One Trading’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-83,449
| Closed | -$366K | – | 7535 |
|
|
2025
Q4 | $432K | Sell |
83,449
-30,135
| -27% | -$155K | ﹤0.01% | 3661 |
|
|
2025
Q3 | $593K | Sell |
113,584
-19,403
| -15% | -$101K | ﹤0.01% | 3519 |
|
|
2025
Q2 | $509K | Sell |
132,987
-31,424
| -19% | -$81.2K | ﹤0.01% | 3405 |
|
|
2025
Q1 | $945K | Sell |
164,411
-39,740
| -19% | -$235K | ﹤0.01% | 2512 |
|
|
2024
Q4 | $1.02M | Buy |
204,151
+174,719
| +594% | +$897K | ﹤0.01% | 2558 |
|
|
2024
Q3 | $159K | Buy |
29,432
+27,586
| +1,494% | +$131K | ﹤0.01% | 3828 |
|
|
2024
Q2 | $6.11K | Sell |
1,846
-4,200
| -69% | -$16.4K | ﹤0.01% | 5871 |
|
|
2024
Q1 | $19.8K | Sell |
6,046
-6,959
| -54% | -$22.9K | ﹤0.01% | 5423 |
|
|
2023
Q4 | $45.6K | Sell |
13,005
-52,541
| -80% | -$162K | ﹤0.01% | 5136 |
|
|
2023
Q3 | $438K | Buy |
+65,546
| New | +$486K | ﹤0.01% | 3039 |
|
|
2023
Q2 | – | Sell |
-100,909
| Closed | -$994K | – | 7600 |
|
|
2023
Q1 | $1M | Buy |
100,909
+86,292
| +590% | +$610K | ﹤0.01% | 2142 |
|
|
2022
Q4 | $102K | Sell |
14,617
-11,296
| -44% | -$64.6K | ﹤0.01% | 4428 |
|
|
2022
Q3 | $138K | Buy |
25,913
+2,597
| +11% | +$15.6K | ﹤0.01% | 4476 |
|
|
2022
Q2 | $93K | Sell |
23,316
-49,752
| -68% | -$171K | ﹤0.01% | 5044 |
|
|
2022
Q1 | $325K | Sell |
73,068
-5,800
| -7% | -$23.1K | ﹤0.01% | 4282 |
|
|
2021
Q4 | $315K | Sell |
78,868
-2,453
| -3% | -$18.7K | ﹤0.01% | 4614 |
|
|
2021
Q3 | $714K | Buy |
+81,321
| New | +$746K | ﹤0.01% | 3784 |
|
|
2021
Q2 | – | Sell |
-60,553
| Closed | -$728K | – | 8089 |
|
|
2021
Q1 | $719K | Buy |
+60,553
| New | +$697K | ﹤0.01% | 3619 |
|
|
2020
Q4 | – | Sell |
-24,162
| Closed | -$170K | – | 6422 |
|
|
2020
Q3 | $179K | Buy |
24,162
+14,415
| +148% | +$93.1K | ﹤0.01% | 3735 |
|
|
2020
Q2 | $41K | Buy |
9,747
+2,645
| +37% | +$9.66K | ﹤0.01% | 4476 |
|
|
2020
Q1 | $18K | Sell |
7,102
-4,073
| -36% | -$18.3K | ﹤0.01% | 4272 |
|
|
2019
Q4 | $65K | Buy |
11,175
+4,912
| +78% | +$28.4K | ﹤0.01% | 3881 |
|
|
2019
Q3 | $33K | Sell |
6,263
-9,200
| -59% | -$49.5K | ﹤0.01% | 4168 |
|
|
2019
Q2 | $93K | Sell |
15,463
-12,092
| -44% | -$91K | ﹤0.01% | 3409 |
|
|
2019
Q1 | $249K | Buy |
+27,555
| New | +$234K | ﹤0.01% | 2538 |
|
|
2018
Q4 | – | Sell |
-457
| Closed | -$4.68K | – | 4814 |
|
|
2018
Q3 | $6K | Sell |
457
-243
| -35% | -$1.97K | ﹤0.01% | 4772 |
|
|
2018
Q2 | $6K | Buy |
+700
| New | +$5.58K | ﹤0.01% | 4755 |
|
Other funds holding ALDX
KCM
KCM
6CM
Group One Trading's ALDX Position: Q1 2026 in Review
Group One Trading sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 83,449 shares — an estimated $366K sold.
Group One Trading first reported a position in ALDX in Q2 2018 and held it in 27 quarters. The position peaked at $1.02M in Q4 2024. 128 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.
- Group One Trading reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 83,449 Aldeyra Therapeutics shares in Q1 2026, an estimated $366K.
- Group One Trading first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 27 quarters.
- Group One Trading's Aldeyra Therapeutics position peaked at $1.02M in Q4 2024.
- 128 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.